Otsuka Holdings Co., Ltd.

4578.T
Drug Manufacturers - General
2026/01/16 Updated
Market Cap: $30.7B (¥4.9T)
Stock Price: $58.09 (¥9,206)
Exchange Rate: 1 USD = ¥158.48

Stock Price Chart

2026/01/16 Updated
12.09
PER (Price Earnings Ratio)
vs Industry Avg: +2.5
1.70
PBR (Price to Book Ratio)
vs Industry Avg: +0.4
1.52%
Dividend Yield
vs Industry Avg: -1.43%

Price Trend

2026/01/16 Updated
Short-term
5-Day MA
+0.38%
Near-term
25-Day MA
+1.12%
Mid-term
75-Day MA
+7.41%
Long-term
200-Day MA
+19.29%

Price & Trading Details

2026/01/16 Updated

PRICE

Previous Close ¥9,158
Open ¥9,174
High ¥9,273
Low ¥9,135
Close ¥9,206

TRADING

Volume 754,300
Average Volume 1,072,503
Turnover ¥69億
Min. Purchase ¥920,600

Analyst Recommendations 12 analysts

Updated 2026/01/11
Strong Buy
2
2
Buy
6
6
Hold
4
4
Sell
0
Strong Sell
0
Target Price (Mean)
¥9,868
Buy
¥11,250
High
¥10,700
Median
¥8,000
Low
+7% vs Current Price
This information is based on market data from third-party data providers and is for reference only. Investment decisions are your own responsibility.

Shareholder Composition

Updated 2026/01/11
14.9%
Insider Holdings
31.7%
Institutional
53.4%
Public Float
352
Institutional Holders
Insider Holdings 14.9%
Institutional 31.7%
Public Float 53.4%

Top Mutual Funds / ETFs

Updated 2026/01/11

Major Holders

Updated 2026/01/11
Fund Name Ownership Shares Change
VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund
1.45%
7.9M 0.00%
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
1.18%
6.4M +0.16%
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
0.75%
4.1M +2.69%
iShares Trust-iShares Core MSCI EAFE ETF
0.55%
3.0M +0.73%
Fidelity Concord Street Trust-Fidelity International Index Fund
0.28%
1.5M -0.16%
iShares, Inc.-iShares MSCI Japan ETF
0.28%
1.5M +0.83%
Institution Ownership Shares Change
Aristotle Capital Management, LLC
0.25%
1.3M -5.05%
Pacer Advisors, Inc.
0.04%
195.7K +4.13%

Dividend History 3Years Growth

Updated 2026/01/11
-%
Dividend Yield
¥140
Annual Dividend
+16.7%
YoY Growth
22.1%
Payout Ratio
Year Dividend Change
2025 ¥140 +16.7%
2024 ¥120 +9.1%
2023 ¥110 +10.0%
2022 ¥100 0.0%
2021 ¥100 -

Financial Performance

2026/01/11 Updated

Revenue & Profit

Margins

Cash Flow

Financial Health

2021 2022 2023 2024
Income Statement
Revenue ¥1,498,276M ¥1,737,998M ¥2,018,568M ¥2,329,861M
Gross Profit ¥1,003,245M ¥1,168,496M ¥1,407,348M ¥1,669,428M
Operating Income ¥152,469M ¥186,064M ¥291,668M ¥415,992M
Pretax Income ¥168,478M ¥179,017M ¥149,178M ¥344,645M
Net Income ¥125,463M ¥133,906M ¥121,616M ¥343,120M
EPS ¥231.15 ¥246.78 ¥224.10 ¥633.76
Operating Margin 10.18% 10.71% 14.45% 17.85%
Balance Sheet
Total Assets ¥2,820,915M ¥3,102,638M ¥3,361,244M ¥3,739,251M
Total Equity ¥2,010,994M ¥2,225,255M ¥2,393,683M ¥2,733,580M
Total Liabilities ¥809,921M ¥877,383M ¥967,561M ¥1,005,671M
Cash ¥410,684M ¥471,634M ¥513,341M ¥426,173M
Interest-bearing Debt ¥212,453M ¥194,161M ¥214,187M ¥189,383M
Equity Ratio 71.29% 71.72% 71.21% 73.11%
D/E Ratio 0.11 0.09 0.09 0.07
Cash Flow
Operating CF ¥228,864M ¥211,848M ¥283,232M ¥354,638M
Investing CF -¥95,288M -¥81,575M -¥190,538M -¥265,793M
Financing CF -¥95,844M -¥95,474M -¥60,260M -¥189,367M
Free CF ¥115,712M ¥104,061M ¥168,559M ¥225,276M
Efficiency
ROE 6.24% 6.02% 5.08% 12.55%
ROA 4.45% 4.32% 3.62% 9.18%

Latest IR Information

  • No IR information found for this company.

    Searched stock code: 4578

Company Information

English Name Otsuka Holdings Co., Ltd.
Japanese Name 大塚ホールディングス(株)
Stock Code 4578.T (JPX)
Sector / Industry Healthcare / Drug Manufacturers - General
Employees 35,338

About

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement equipment, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, quasi-drugs, household products, and packaging materials and electronic parts. In addition, the company offers IT solutions; adhesive tapes; flaky titanate and compounds; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams. Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; rental of space and office businesses; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table. The company was founded in 1921 and is headquartered in Tokyo, Japan.

Data provided by Yahoo Finance